Testing effectiveness (Phase 2)Study completedNCT01994629
What this trial is testing
Safety and Immunogenicity of One Dose of Novartis' Meningococcal ACWY-CRM Vaccine and GlaxoSmithKline Biologicals' Meningococcal ACWY-TT Vaccine in Healthy Toddlers
Who this might be right for
Meningococcal Disease
Novartis Vaccines 202